Researchers in Northern India have found that patients ≤45 years diagnosed with coronary artery disease (CAD) have higher lipid levels than CAD patients aged 55 to 75 years, according to a recently published study. “Our study reconfirms that the mean lipid levels in North Indian patients inflicted with CAD are…
Read more »
In patients with cancer who had an acute myocardial infarction (AMI) the use of beta-blockers and aspirin were each associated with improved survival. The population was primarily comprised of patients with non-ST-segment elevation myocardial infarction (NSTEMI). This was the main finding of a recent observational study published in Clinical Cardiology….
Read more »
Calcium supplements are commonly recommended to the elderly and post-menopausal women for optimal maintenance of bone health. Previous research has reported that a higher calcium intake may lead to a decrease in risk factors for myocardial infarction (MI) and stroke, including hypertension, type 2 diabetes, and obesity. “In a country…
Read more »
Heart failure is a common disease with high morbidity and mortality. Based on disease-specific estimates of prevalence and incidence rates of heart failure, it is estimated that the prevalence of heart failure in India due to coronary heart disease, hypertension, obesity, diabetes, and rheumatic heart disease range from 1.3 million…
Read more »
An estimated 5.2 million deaths per year in India are caused by noncommunicable diseases (NCDs), and the number is expected to grow in the coming decades. “Physicians have an important role to play—not only as caregivers but also as counselors, educators, and community leaders. They can convey the message that…
Read more »
Blood levels of the carbohydrate-binding protein galectin-3 identified patients with ischemic heart failure who derived significant clinical benefit from rosuvastatin in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) trial. A substudy of CORONA demonstrated that patients with blood levels of galectin-3 <19.0 ng/mL at the start of the…
Read more »
indicates a Peer-Reviewed Article
Elderly hypertensive patients with cardiovascular disease may benefit from combination antihypertensive therapy
Adding a second antihypertensive medication appears to be more beneficial than increasing the dose of a single antihypertensive in reducing all-cause mortality cardiovascular outcomes in patients with cardiovascular disease (CVD). This was the main finding of a recent randomized trial that sought to determine the efficacy of high-dose angiotensin receptor…
Read more »